Wyeth’s Torisel To Launch In July Following FDA Approval

 
• By Jonathan M. Block

Renal cell carcinoma treatment will compete with Bayer/Onyx’s Nexavar and Pfizer’s Sutent.

More from Archive

More from Pink Sheet